The Effects of Tai Chi on Metabolic Dysfunction-associated Fatty Liver Disease in Middle-Aged and Older Adults

Not Applicable

Recruiting

• Conditions: Non-Alcoholic Fatty Liver Disease

• Registration Number: NCT06717828
• Lead Sponsor: Fujian Provincial Hospital

Brief Summary

Background: Metabolic dysfunction-associated fatty liver disease (MAFLD) is a liver condition primarily driven by metabolic dysfunctions that may progress to hepatitis, cirrhosis, and hepatocellular carcinoma. It is also implicated in the development of other metabolic dysfunction-related diseases. MAFLD has emerged as a growing public health concern in China. Despite its potential benefits, Tai Chi exercise has not been widely adopted for individuals with MAFLD, and there is limited research investigating its therapeutic efficacy. This study aims to evaluate the effects of a structured Tai Chi intervention on middle-aged and elderly individuals with MAFLD.

Methods: The study employs a comprehensive open, randomized, parallel, and controlled design. Eligible participants will be randomly allocated into three groups: Tai Chi, conventional exercise, and control. A total of 250 participants will be enrolled, comprising 100 participants each for the Tai Chi and conventional exercise groups and 50 for the control group. Both the Tai Chi and conventional exercise groups will participate in a structured 6-month exercise program. During the intervention, both groups will also receive regular health education on fatty liver disease. Participants will be encouraged to maintain their usual activities but will be advised against starting new exercise regimens. The control group will receive only health education on fatty liver disease. The primary efficacy endpoint is the change in hepatic triglyceride content measured via validated imaging techniques after 6 months. Secondary endpoints include changes in total body fat, waist circumference, body weight, blood pressure, blood lipids, blood glucose, insulin sensitivity, pancreatic beta-cell function, kidney function, and pulse wave velocity. Outcomes will be assessed at baseline and post-intervention.

Discussion: Tai Chi exercises demonstrate therapeutic potential in reducing intrahepatic fat content, promoting weight loss, and mitigating cardiovascular risk factors. Furthermore, their efficacy appears superior to that of conventional exercise modalities.

Detailed Description

Not available

Study Timeline

• Study Start: 2024-11-01
• Status Verified: 2024-12
• Study First Submitted: 2024-12-01
• Study First Submitted QC: 2024-12-01
• Last Update Submitted: 2024-12-01
• Study First Posted: 2024-12-05
• Last Update Posted: 2024-12-05
• Primary Completion: 2026-12-31
• Study Completion: 2026-12-31

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 250

Inclusion Criteria

1. Age between 40 and 75 years;
2. Liver fat content measured by mDixon QUANT is ≥5%;
3. Diagnosis of metabolic associated fatty liver disease;
4. Overweight/obesity (BMI ≥ 24 kg/m²);
5. Signed written informed consent.

Exclusion Criteria

1. Excessive alcohol consumption (definition: in the past 6 months, males have consumed more than 140g of alcohol per week, and females have consumed more than 70g);
2. Fatty liver due to other causes: such as alcoholic fatty liver, acute and chronic viral hepatitis, drug-induced hepatitis, autoimmune hepatitis, etc.;
3. Severe cardiovascular diseases, including myocardial infarction within the past 6 months;
4. Heart failure (NYHA classification: III - IV);
5. Biliary diseases: such as obstructive biliary diseases;
6. Other diseases affecting glucose and lipid metabolism: diabetes, hyperthyroidism, hypothyroidism, Cushing's syndrome, etc.;
7. Poorly controlled blood pressure: SBP ≥ 180 mmHg, DBP ≥ 100 mmHg;
8. Chronic kidney disease or severe renal impairment, defined as serum creatinine of 135 µmol/L (1.5 mg/dL) for males and 110 µmol/L (1.3 mg/dL) for females;
9. Patients unable to communicate normally, such as those with dementia or cognitive impairment;
10. Currently pregnant or planning to become pregnant in the near future;
11. Other conditions preventing participation in follow-up interventions;
12. Other clinical diseases that make participation in exercise unsuitable, such as inability to cooperate with exercise therapy due to severe pain or joint deformities, or the use of medications that may interfere with the assessment of exercise effects (such as corticosteroids, liver protection drugs, etc.), or medications that affect heart rate (such as beta-blockers).

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Determination of Liver Fat Content	Baseline (month 0) to post-training (month 6)	The liver is scanned using a SIEMENS 3.0T MRI (Magnetom Prisma, Siemens Healthineers, Germany). Participants lie supine, holding breath at end-expiration. A 3D multi-echo water-fat separation gradient echo sequence is used with parameters: TR 9.00 ms, TE1-6 at 1.05-7.38 ms, 4° flip angle, 450×394 mm FOV, 1.4×1.4×3.5 mm voxel size, 64 slices, 13 sec collection time. Images include in-phase, out-of-phase, water, fat, fat fraction, and R2\* relaxation. Liver fat content (%) is measured in pseudocolor mode. ROIs are selected in liver's left lobe, central right lobe, and posterior right lobe below the portal vein at two levels, each 4 cm², avoiding bile ducts and vessels. Average fat content from 9 ROIs represents total liver fat content.

Secondary Outcome Measures

Name	Time	Method
Body weight	Baseline (month 0) to post-training (month 6)	The measurement is conducted in the morning on an empty stomach, with advance notice given to participants.A standardized scale provided by the research center is placed on a flat surface.Participants are required to remove shoes, hats, and outerwear, and to wear only a single layer of clothing, removing any personal items such as wallets and phones.Participants stand calmly on the scale with their feet symmetrically positioned. Their bodies should be upright, arms naturally relaxed at their sides, head straight, and eyes looking forward.Measurements are taken twice, recording the average, ensuring that the discrepancy between the two measurements is less than 1.0 kg, with precision to 0.1 kg. Participants are advised to maintain an upright posture.
Waist circumference	Time Frame: Baseline (month 0) to post-training (month 6)	Waist circumference is measured in the morning after fasting. Subjects must stand upright with relaxed abdomen, arms down, and feet together. Use a metric tape at the midpoint between the lower ribs and upper iliac crest (about 1 cm above the navel), wrapped snugly but not compressing the skin. Subjects should breathe normally with a relaxed abdomen, and the measurement is taken at the end of exhalation, avoiding abdominal muscle contraction or breath holding. Repeat twice and record the average, ensuring measurements differ by less than 2 cm, accurate to 0.1 cm.
Blood pressure	Baseline (month 0) to post-training (month 6)	Subjects must avoid heavy exercise, training, eating, drinking (except water), caffeine, extreme temperatures, and blood pressure-altering meds before measuring. Stop smoking 30 min prior. Relax, empty bladder, rest 5 min. Measure BP in a comfortable room, seated naturally with back straight, palms up. Cuff on bare skin, 1-2 cm above inner elbow, not covering joint, tube aligned with middle finger. Cuff center at heart level. After one measurement, loosen cuff, let subject move arm slightly, then rest 1-2 min before next. Take three measurements, 1 min apart, to 1 mmHg precision.
Grip strength of both hands	Baseline (month 0) to post-training (month 6)	Using a calibrated hand dynamometer (Brand: CAMRY, Model: EH101).Subjects may stand or sit with their upper limbs naturally hanging at their sides. The palm should face the inner side of the body, with the handle of the dynamometer facing outward.Subjects should grip the dynamometer firmly to measure their grip strength, maintaining a stable posture without swinging the dynamometer back and forth during the measurement.Measure three times and record the maximum value. The dynamometer should be reset to zero before each measurement. Values should be recorded with a precision of 0.1 kg. The measurement can be conducted in the order of right hand followed by left hand.
Body fat percentage	Baseline (month 0) to post-training (month 6)	Using the BIA method, which calculates the proportion of fat and non-fat tissues based on the principle that well-hydrated tissues like muscles and blood vessels conduct electricity well, while fat tissue hardly conducts electricity at all.Measurements should be taken in a fasting state in the morning or more than 2 hours after a meal, with prior notification to the subjects; subjects should avoid vigorous exercise, saunas or baths, excessive alcohol consumption, and the intake of large amounts of water or food (1-2 hours before).Place the body fat analyzer (InBody 770, provided by the research center) on a flat, hard surface. The subject should stand barefoot on the foot electrodes of the body fat analyzer with dry skin, straighten the back and knees, raise the arms horizontally, extend the elbows, and position the arms at a 90° angle from the body with the palms pressed against the electrodes.Precision is to 0.1%.
Total body fat	Baseline (month 0) to post-training (month 6)	To measure total body fat, a DEXA densitometer scans subcutaneous fat and body composition. Subjects wear minimal clothing, remove metals, and lie centered on the scanning bed, aligned with the midline. For wider bodies, a half-body scan is possible. The scan includes the head, spine, and one side of the body, with the head 3 cm below the bed's horizontal line. Hands are positioned thumbs up, palms to legs, and arms alongside the body. Nylon straps secure knees and feet. Start the scan from the toolbar, monitor the image for full body display, and reposition if needed. Composition results show fat percentage, and detailed reports are printed from the Reports dialog box.
Liver fibrosis scanning to determine liver stiffness	Baseline (month 0) to post-training (month 6)	The FibroScan PRO-S by Echosens measures liver elasticity to assess hardness. Subjects lie supine with the right arm extended. Operators sit on the right, facing the subject and screen, placing the probe between ribs near the liver's right lobe, avoiding the edge. Use A-mode and M-mode to find a 6 cm deep, vascular-structure-free area, keeping the probe perpendicular to the skin. Press until the pressure indicator is green, then press the probe button for 1/10 sec data acquisition. Check the elastogram quality. For disinfection, end the exam, wipe off gel, and clean the probe tip with an alcohol-free disinfectant. Calibrate the probe every 12 months.
Abdominal visceral fat	Baseline (month 0) to post-training (month 6)	Abdominal visceral fat measurement is performed using the SIEMENS 3.0T MRI instrument (Magnetom Prisma, Siemens Healthinners, Erlangen, Germany). During the examination, subjects lie in a supine position and hold their breath while a single-layer cross-sectional MRI scan is taken at the L4-L5 level. After the acquisition, Image J software is used to analyze the area of abdominal visceral fat.
Blood specimen	Baseline (month 0) to post-training (month 6)	Lab tests include OGTT at 0, 30, 120 min, serum insulin at 0, 30, 120 min, HbA1c, lipids, liver and kidney function. Fasting blood is collected early morning by trained nurses. For OGTT (7-9 a.m.), subjects fast 8-10 hours and drink 75g anhydrous glucose in 300ml water (or 82.5g monohydrate) within 5 min. Blood samples are taken pre-test and at 30, 120 min post-glucose. Avoid tea, coffee, smoking, and heavy exercise. Samples are sent to Fujian Provincial Hospital lab for uniform testing, following standards and accredited.

Trial Locations

Locations (1)

Fujian Provincial Hospital; 🇨🇳 Fuzhou, Fujian, China